Clinical Trial Update: Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of ranolazine on blood markers in women with stable angina and metabolic syndrome; study completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Stable Angina

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: University of Florida | Conditions: Stable Angina, Metabolic Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2020-04-10